Genitourinary Cancers Special Issue
Within the genitourinary cancer space, there have been many treatment advances over the past year.
As part of the “Speaking Out” series, a radiation oncologist discusses the benefits of MRI-guided stereotactic body radiation therapy.
Antibody-drug conjugates represent a paradigm shift for patients with cancer and providers.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
FDA Withdraws Krazati/Erbitux Approval in KRAS G12C-Mutated Colorectal Cancer
3
FDA Grants Accelerated Approval to Hyrnuo for Certain Patients With HER2-Mutated NSCLC
4
Bristol Myers Squibb Reports Positive Results for CAR T-Cell Therapy in Heavily Pretreated Multiple Myeloma
5